Founded in 1995, Snyder is a state-level high-tech enterprise specializing in the research, development, production and sales of "automatic chemiluminescence immunoassay analyzer and supporting in vitro diagnostic reagents". Its products are mainly used to provide diagnostic information for disease prevention, diagnosis, treatment and detection, prognosis observation, health status assessment and genetic disease prediction. It is in a leading position in the field of chemiluminescence immunoassay in China. On July 20 14, the company was listed on the national share transfer system for small and medium-sized enterprises (code 830838).
The company has more than 800 employees, more than 80% of whom have bachelor degree or above, and more than 90 doctors, masters and returnees. The company has three professional teams: reagent R&D and production center, instrument R&D and manufacturing center and marketing center to support the company's rapid development. 20 14 in the first half of the year, the company's operating income increased by 60. 16%, and its net profit increased by 98.2 1%. At the beginning of 20 15, the company's fully automatic chemiluminescence immunoassay system R&D and production base were put into use, with nearly 9,000 square meters of instrument production workshop and more than 4,000 square meters of 6,543,800+class clean workshop, which can realize the annual production capacity of 2,500 fully automatic chemiluminescence analyzers and 6,543,800+5,000 boxes of supporting reagents. The company's marketing center covers domestic marketing department, overseas marketing department, marketing department, domestic technical service department and overseas technical service department, and has set up 15 offices in South China, East China, North China, Northeast China, Southwest China, Northwest China and Central South China, as well as maintenance service centers in various provinces and cities. The marketing and service network has covered all regions of the country. In addition, the company actively expands overseas markets and has established cooperative relations with agents in more than 90 countries and regions such as Italy, Spain, Switzerland and Colombia.
Since its establishment, the technology development company has been committed to the research and development in the field of chemiluminescence immunoassay. After 15 years of painstaking research, automatic chemiluminescence immunoassay products and supporting reagents were officially put on the market in February 20 10. It is the first company in China to apply direct chemiluminescence immunoassay technology to realize the mass production of automatic chemiluminescence immunoassay instruments and supporting reagents. The automatic chemiluminescence immunoassay technology developed by the company fills the last blank of in vitro diagnostic reagents in China, and also breaks the situation that this field has been monopolized and blocked by Roche, Abbott, Siemens and Beckman for a long time, and becomes the leader in the field of chemiluminescence immunoassay in China. Since its establishment, the company has successfully developed a series of magnetic separation direct chemiluminescence immunoassay products and more than 100 kinds of in vitro diagnostic reagents, including tumor markers, myocardial markers, liver fibrosis, hormones, glucose metabolism, bone metabolism and other detection reagents, with nano-composite immunomagnetic beads as the core technology platform, which has made important contributions to the domestic clinical laboratory industry. It is the first company in China and the fifth company in the world to adopt the most advanced "nano-immunomagnetic beads" as the key separation material of the system; It is the first company in China and the fourth company in the world to use the most advanced "synthetic small molecular organic compounds" in this field instead of traditional enzymes as luminescent markers; It is the first in the world to use RFID electronic tag identification technology to store and read reagent-related information, which has the characteristics of large amount of information stored and fast and reliable reading.
Company honor was recognized as "Shenzhen High-tech Enterprise" in 2002; In 2005, he won the "Shenzhen Science and Technology Award" and passed the CMD certification; In 2007, it passed the EU CE certification and was recognized as a "national high-tech industrialization demonstration project" unit; In 2009, it was recognized as a "national high-tech enterprise", and in the same year it was certified as an "independent innovation product of Guangdong Province", and passed the ISO900 1 certification and ISO 13485 certification; 20 10 was recognized as a "double soft enterprise"; 20 12 won the "Shenzhen automatic chemiluminescence immunoassay system engineering technology research and development center" and so on.
Company headquarters address: Floor A, Software Industry Base, Keyuan Road 1008, Nanshan District, Shenzhen 19-2 1.
R&D and production base:No. Jinhui Road 16, Jinsha Community, Pingshan New District, Shenzhen.
Legal Representative: Rao Wei.
Date of establishment:1995-12-15.
Registered capital: 370.4 million yuan.
Location: Guangdong Province
Unified social credit code: 914403001923998520.
Business status: surviving (in business, in business, on record)
Industry: wholesale and retail trade
Company Type: Limited by Share Ltd (unlisted)
English name: Shenzhen New Industry Biomedical Engineering Co., Ltd.
Number of employees: 1000-4999.
Address:No. Jinhui Road 16, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen.
Scope: setting up industries (specific projects shall be declared separately); Information consultation (excluding franchise, exclusive control, monopoly goods and restricted articles). Engaged in import and export business (according to the provisions of Shenzhen Trade Management Zhunzi No.2002-452 qualification certificate); Software development and production (computer production only, excluding production line). Purchase and sale of clinical laboratory analytical instruments and reagents, daily chemicals and mechanical and electrical products; Category III: 6823 medical ultrasonic instruments and related equipment, 6824 medical laser instruments and equipment, 6825 medical high-frequency instruments and equipment, 6828 medical magnetic vibration equipment, 6830 medical X-ray equipment, 6840 clinical examination and analysis instruments, 6840 in-vitro diagnostic reagents, 6854 operating room, emergency room and outpatient equipment and appliances, and all the second-class medical instruments (including the second-class in-vitro diagnostic reagents). Development and production of 6840 clinical inspection and analysis instruments of Class II and III, and 6840 in-vitro diagnostic reagents of Class I, II and III [the production project is specially approved according to Guangdong Xu No.20000003 Medical Device Production License and the environmental impact assessment reply of the construction project of Shenzhen Environmental Protection Bureau]; Production and sales of non-medical devices matching licensed medical device products.